We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
59 hedge funds and large institutions have $119M invested in ESSA Pharma in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
1.23% more ownership
Funds ownership: 84.5% → 85.73% (+1.2%)
16% less funds holding
Funds holding: 70 → 59 (-11)
48% less capital invested
Capital invested by funds: $230M → $119M (-$111M)
52% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 21
58% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 19
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
59
Holders Change
-11
Holders Change %
-15.71%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
10
Reduced
21
Closed
19
Calls
$56K
Puts
–
Net Calls
+$56K
Net Calls Change
-$88K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$11.8M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$5.37M |
| 3 |
JP Morgan Chase
New York
|
+$1.13M |
| 4 |
Millennium Management
New York
|
+$697K |
| 5 |
HF
HRT Financial
New York
|
+$299K |
Top Sellers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$4.5M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$3.15M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.79M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.32M |
| 5 |
BlackRock
New York
|
-$525K |
